Your session is about to expire
← Back to Search
Anesthetic Techniques for Pain and Anesthesia
Study Summary
This trial will compare the effects of two anesthetic techniques on natural killer cells in patients undergoing abdominal surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a BMI over 40 or weigh more than 150 kg.I have HIV or another condition that weakens my immune system.I am allergic or cannot tolerate fentanyl or bupivacaine.My blood pressure is not higher than 140/90.I have a heart condition known as prolonged QT syndrome.I am not taking medications known to affect heart rhythm.I experience nerve pain.I do not have active liver failure or cirrhosis.My blood levels of potassium, magnesium, or calcium are low and not corrected.I take more than 30mg of oxycodone or equivalent daily.I am experiencing significant weight loss and muscle wasting.I have used corticosteroids for more than 2 weeks in the last 6 months.I cannot tolerate certain pain medications given through the spine.I can have an epidural.I do not have an infection or skin issue where my epidural was placed.I cannot or do not want to have an epidural for pain control due to back issues or personal choice.I am between 18 and 80 years old.I am scheduled for surgery to explore my abdominal tumor.I have had a heart attack or abnormal heart stress test in the last 3 months.My kidney function is impaired with creatinine over 2.0 mg/dL.
- Group 1: 'Bupivacaine + Fentanyl' (Opioid Group)
- Group 2: Bupivacaine (Local Anesthetic Group)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been accepted into this research project thus far?
"Unfortunately, we are not currently admitting participants for this trial. It was initially posted on July 10th 2019 and amended last February 9th 2022. Should you be looking into other trials, there are presently 942 studies recruiting patients with malignancies and 141 experiments seeking individuals who can benefit from Bupivacaine + Fentanyl treatments."
To what extent have researchers investigated the potential of Bupivacaine + Fentanyl?
"Currently, there are 141 ongoing studies concerning the combination of Bupivacaine and Fentanyl with 26 tests at phase 3. Most clinical experiments for this mixture take place in Germantown, Tennessee yet 204 sites across the world have trials involving it."
Is this experiment actively seeking participants?
"This clinical trial has closed its recruitment phase, with the initial post on July 10th 2019 and last edit made February 9th 2022. However, there are still numerous studies recruiting participants for malignancies (942) and Bupivacaine + Fentanyl specifically (141)."
What medical ailments is the Bupivacaine + Fentanyl combination employed to alleviate?
"Bupivacaine + Fentanyl serves as a usual line of treatment for permphigus while also being prescribed to patients with acute nonspecific tenosynovitis, general anaesthesia and lupus erythematosus cell."
Does this trial cater to participants aged over twenty?
"To be qualified for this medical trial, participants must fall within the age bracket of 18 to 80 years old."
Am I eligible to join the experiment?
"The requirements to join this trial are a malignant condition and an age between 18 and 80. Currently, the clinical trial is searching for 20 participants in total."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger